MOLTIME-XT
MRP: 4,100
Packaging: 10x1 Combikit
Pack Type: tablet
Composition:
Combikit of Calcium Carbonate 500mg + Vitamin D3 500IU + Zinc 7.5mg + Ibandronic Acid 150 mg
Indication:
Postmenopausal Osteoporosis & Osteoporosis in Men
Description:
OsteoCare Combikit is designed for post-menopausal osteoporosis, steroid-induced bone loss, and low-bone-density states.
Ibandronic Acid 150 mg (once monthly) is a third-generation bisphosphonate that binds to hydroxy-apatite in bone, inhibits osteoclast-mediated resorption, and increases bone-mineral density.
Daily chewable tablets supply elemental calcium 500 mg (from calcium carbonate), Vitamin D3 500 IU to enhance calcium absorption, and Zinc 7.5 mg to support collagen cross-linking and bone remodeling.
This convenient kit simplifies adherence: 1 high-potency bisphosphonate on day 1 of each month + one mineral-vitamin tablet every day.
Tags:
- Once-a-month bisphosphonate improves adherence versus weekly regimens.
- Daily chewables ensure constant calcium-D-zinc supply for optimal bone deposition.
- Reduces vertebral fracture risk up to 50 % in post-menopausal women (clinical data).
- Convenient all-in-one packaging improves patient compliance.
Usage Information
Dosage
Component Dose & Timing Key Instructions Ibandronic Acid 150 mg once on Day 1 each month, morning, empty stomach Swallow whole with 240 mL plain water; no food, drink, or meds for 60 min; stay upright. Calcium/D3/Zinc 1 chewable tablet daily after a meal Avoid taking within 2 h of iron, tetracyclines, or levothyroxine.
Side Effects
Ibandronic Acid Mineral-Vitamin Tablet Dyspepsia, oesophageal irritation, musculoskeletal pain, rare osteonecrosis of jaw Mild constipation, bloating, metallic taste
Contraindications
Hypocalcaemia (correct before starting) Severe renal impairment (eGFR < 30 mL/min) Oesophageal strictures or inability to sit/stand 60 min Known hypersensitivity to any component